Compare StocksABT vs XOM

Abbott Laboratories (ABT) vs ExxonMobil Holdings Corporation (XOM): Which Is the Better Buy in 2026?

As of 2026-08-03, ABT is overvalued at $106, with a DCF intrinsic value of $89 and a margin of safety of -18%. XOM is undervalued at $155, with an intrinsic value of $459379071521 and a margin of safety of 100%. Of the two, XOM has the wider margin of safety.

ABT
Abbott Laboratories
$105.70
VS
XOM
ExxonMobil Holdings Corporation
$155.44

Rewards

ABT
  • Abbott Laboratories scores 86/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Altman Z-Score of 5.60 indicates very low bankruptcy risk — the company is firmly in the safe zone.
XOM

    Risks

    ABT
    • Trailing P/E of 34.2x is 26% above the historical average of 27.2x — the stock trades at a premium to its own history.
    • PEG ratio of 2.13 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
    XOM
    • ROIC has declined by 12.0 percentage points over the past 4 years, which may signal competitive erosion.
    • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
    • Trailing P/E of 26.2x is 104% above the historical average of 12.8x — the stock trades at a premium to its own history.

    Key Valuation Metrics

    Learn more →
    ABT
    XOM
    Valuation
    $7.21B
    Free Cash Flow
    $20.67B
    3.94%
    FCF Yield
    N/A
    34.21
    Trailing P/E
    26.17
    17.43
    Forward P/E
    14.69
    Quality & Moat
    6.41%
    ROIC
    14.66%
    10.58%
    ROE
    12.58%
    56.85%
    Gross Margin
    29.77%
    2.13
    PEG Ratio
    1.32
    Balance Sheet Safety
    0.52
    Net Debt / Equity
    0.12
    N/A
    Interest Coverage
    N/A
    2.32
    Net Debt / EBITDA
    0.47
    2.38%
    Dividend Yield
    2.65%
    ABT: 1Ties: 1XOM: 9
    ABTXOM

    Historical Fundamentals

    Learn more →
    ABT

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    XOM

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABT
    $1.89
    created per $1 retained over 3 years
    Value Creator
    Σ Retained
    $14.14B
    Δ Market Cap
    +$26.79B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    XOM
    $0.00
    created per $1 retained over 3 years
    Value Destroyer
    Σ Retained
    $49.66B
    Δ Market Cap
    +$10.04
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABT
    18.2% Overvalued
    Price is 18.2% above estimated fair value
    Current Price: $105.70
    Fair Value: $89.41
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    XOM
    100.0% Margin of Safety
    Price is 100.0% below estimated fair value
    Current Price: $155.44
    Fair Value: $459379071520.71
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABT

    What growth rate is the market pricing in at $106?

    +12.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +12.8%

    The market implies +12.3% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +12.8%, reflecting heavy growth investment.

    XOM

    What growth rate is the market pricing in at $155?

    -30.0%
    Market-Implied FCF Growth Rate

    Market below historical growth — potential opportunity.

    Economic Moat Score

    Learn more →
    ABT
    86/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Margin Stability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    XOM
    48/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with reinvestment efficiency as the key competitive advantage. Improving margin stability would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABT
    -2.48
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    XOM
    -2.74
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABT
    Insiders 0.5%Institutions 83.0%Retail & Other 16.5%
    No. of Institutional Holders3,843
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    XOM
    Insiders 0.1%Institutions 68.8%Retail & Other 31.2%
    No. of Institutional Holders5,341
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABT
    1
    Buys (3M)
    5
    Buys (12M)
    Total value (12M): $4.40M
    STRATTON JOHN G.
    Director
    $173,640
    @ $86.82 · 2026-05-07
    STARKS DANIEL J
    Director
    $926,537
    @ $92.65 · 2026-04-27
    BOUDREAU PHILIP P
    Chief Financial Officer
    $201,300
    @ $91.50 · 2026-04-23
    STARKS DANIEL J
    Director
    $1.09M
    @ $108.73 · 2026-02-04
    FORD ROBERT B.
    Chief Executive Officer
    $2.01M
    @ $107.13 · 2026-01-23
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    XOM
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABT
    0
    Sells (3M)
    8
    Sells (12M)
    Total value (12M): $1.44M
    SALVADORI DANIEL GESUA SIVE
    Officer
    $102,288
    @ $115.58 · 2026-03-02
    MCCOY JOHN A. JR
    Officer
    $67,614
    @ $115.58 · 2026-03-02
    MORRONE LOUIS H
    Officer
    $132,224
    @ $115.58 · 2026-03-02
    SHROFF ERIC
    Officer
    $81,946
    @ $115.58 · 2026-03-02
    CUSHMAN ELIZABETH C
    General Counsel
    $30,398
    @ $115.58 · 2026-03-02
    MORELAND MARY K
    Officer
    $70,851
    @ $115.58 · 2026-03-02
    SHROFF ERIC
    Officer
    $203,043
    @ $128.02 · 2025-11-25
    BOUDREAU PHILIP P
    Chief Financial Officer
    $746,758
    @ $134.55 · 2025-08-08
    BLOUNT SALLY E
    Director
    $337,116
    @ $129.66 · 2025-04-30
    EARNHARDT LISA D
    President
    $12.23M
    @ $133.83 · 2025-03-07
    MCCOY JOHN A. JR
    Officer
    $77,652
    @ $138.17 · 2025-03-03
    SHROFF ERIC
    Officer
    $77,652
    @ $138.17 · 2025-03-03
    MORELAND MARY K
    Officer
    $109,292
    @ $138.17 · 2025-03-03
    MORRONE LOUIS H
    Officer
    $153,507
    @ $138.17 · 2025-03-03
    WAINER ANDREA F
    Officer
    $131,123
    @ $138.17 · 2025-03-03
    FORD ROBERT B.
    Chief Executive Officer
    $37.44M
    @ $131.17 · 2025-02-05
    SALVADORI DANIEL GESUA SIVE
    Officer
    $3.05M
    @ $128.50 · 2025-01-30
    ALLEN HUBERT L.
    Officer
    $24.34M
    @ $128.26 · 2025-01-30
    ALLEN HUBERT L.
    Officer
    $18.42M
    @ $117.04 · 2024-10-21
    FORD ROBERT B.
    Chief Executive Officer
    $16.49M
    @ $116.41 · 2024-09-12
    MCCOY JOHN A. JR
    Officer
    $3,100
    @ $114.81 · 2024-09-04
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    XOM
    0
    Sells (3M)
    0
    Sells (12M)
    No open market insider sales found.
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABT
    FearGreed
    😐Neutral(53/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    XOM
    FearGreed
    😏Greed(65/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABT
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
    XOM
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (65)
    View ABT Full AnalysisView XOM Full Analysis

    Frequently Asked Questions: ABT vs XOM

    Is Abbott Laboratories or ExxonMobil Holdings Corporation more undervalued in 2026?

    Based on our discounted cash flow model, XOM trades at a 100.0% margin of safety (intrinsic value $459379071521 vs. price $155), compared to ABT's -18.2% margin of safety (intrinsic $89 vs. $106).

    Which stock has a wider economic moat, Abbott Laboratories or ExxonMobil Holdings Corporation?

    ABT scores 86/100 (Wide moat), while XOM scores 48/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is ExxonMobil Holdings Corporation in financial distress?

    XOM's Altman Z-Score of 2.5 places it in the Grey zone, signaling elevated bankruptcy risk. ABT scores 5.6 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, Abbott Laboratories or ExxonMobil Holdings Corporation?

    XOM earns 14.7% ROIC versus ABT's 6.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Abbott Laboratories's or ExxonMobil Holdings Corporation's?

    ABT's dividend earns a safety score of 84/100 (Very Safe), compared to XOM's 69/100 (Safe). ABT has raised its dividend for 3 consecutive years.

    ABT vs XOM: Which Is the Better Buy in 2026? | SafetyMargin.io